SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (374)1/10/2002 11:43:28 AM
From: richardred  Read Replies (1) of 724
 
Richard-My thoughts Exactally-Although a takeover of NBSC is only speculation. It's only one piece of the investment picture here. There's factual information in Fishers,and AOT's business models-(witch includes acquisition)thats a fact. Richard H. has posted some of Fishers business model facts. I have posted some of Apogents below. Anybody can plainly see both models include acquisitions. It might not ever be realized here, but when your putting together a big puzzle. It helps to know where the pieces fit, and who's building the puzzle, if you speculate in this area. Sometimes that puzzle makes a picture of a dollar sign if completed. Sometimes the puzzle is never completed, but you can still make money while waiting.

RR

Apogent- is a worldwide leader in the design, manufacture and sale of the highest quality life science and analytical products. We produce thousands of value-added, specialty and state-of-the-art laboratory products for the clinical, research and industrial markets.Through our commitment to product development, our signature customer-focused approach and the (acquisition) of quality, product-leading companies, Apogent supplies laboratories around the world with the highest quality of products available.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext